World of DTC Marketing
FEBRUARY 21, 2022
Reportedly, the cost of production for molnupiravir stands at about $17.74. The study adds further evidence to the idea that drug copay cards are a great short-term deal for patients — and especially the pharma companies that promote them — but a wrong long-term value for healthcare costs. costs about $700. spending annually.
pharmaphorum
JUNE 10, 2022
If you work in pharma, the chances are you’re no stranger to the United States Food and Drug Administration, or FDA, which regulates pharmaceuticals. While the FDA is responsible for regulating both drugs and devices, they’re handled through completely different processes in different parts of the agency.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 2, 2020
The UK’s medicines regulator has published long-awaited guidance on regulation of medicines and medical devices as the UK approaches the end of its Brexit transition period at the end of the year. Companies face significant changes in how the complex environment for medicines regulations will operate in 2021. “If
pharmaphorum
FEBRUARY 14, 2022
A recent report has found that R&D productivity rose vertiginously during 2021, but how much of this was organic and how much can be attributed to the pandemic? The pandemic also saw a reduction in the overall development cycle of a product, which has been growing in recent years. In 2020, the development cycle averaged 7.14
pharmaphorum
AUGUST 17, 2020
In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Within this, the progressive pharma companies are utilising modular content to increase brand standards.
Pharmaceutical Technology
FEBRUARY 24, 2023
EU competitiveness Moll said the legislation revisions should instead be used to make Europe more attractive to pharma companies. But others do not accept that the EU is less competitive for the pharma industry than North America and Asia. If you measure everything on faster, I’m not sure Europe will always come out ahead.”
Pharmaceutical Technology
MARCH 30, 2023
The US FDA has revealed its detailed budget proposal for FY2024, which would require pharma companies to name their active pharmaceutical ingredient (API) suppliers, restart President Biden’s Cancer Moonshot, inject cash into amyotrophic lateral sclerosis (ALS) research, and enforce stricter rules around manufacturing, recalls, and shortages.
Expert insights. Personalized for you.
218 
Let's personalize your content